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Introduction
Practice guidelines are intended to
ensure quality and promote the effective-
ness of health care.1"2 A popular method
of guideline development uses group
judgments that incorporate expert physi-
cian opinions and beliefs.2 Reliance on
experts' opinions may call into question
thejudgments ofcommunity physicians by
implying that a difference exists between
the two standards, a discrepancy that
could ultimately affect practitioners' ac-
ceptance of practice guidelines.3 Al-
though the methodologic validity ofexpert-
derived guidelines has been questioned,4
to our knowledge no study has examined
the degree to which experts' and commu-
nity physicians' beliefs about the appropri-
ateness of the same procedures differ.
Therefore, we compared two sets of
appropriateness ratings for hysterectomy,
the second most common surgical proce-
dure in the United States.5 One set was
given to a national expert managed care
panel, and the other to practicing commu-
nity gynecologists in North Carolina, a
state with one of the highest rates (59/
100 000) and wide variation (33-103/
100 000) in use of hysterectomy.6
Methods
Survey Paricipants
We surveyed two physician groups,
one a weighted random sample of 231
North Carolina gynecologists (weighted
to include one-third female and two-
thirds male gynecologists) who performed
at least one hysterectomy in the past year
and were licensed by the North Carolina
Board of Medical Examiners (n = 671).
The second was a group composed ofnine
physicians nominated by members of the
Health Maintenance Organization (HMO)
Quality of Care Consortium.7
Survey Methods
Forty-one North Carolina gynecolo-
gists were excluded because they were not
surgically active or could not be con-
tacted. Of the remaining 190 eligible
gynecologists, 140 responded (74% re-
sponse rate). The nine HMO Quality of
Care Consortium panelists completed the
North Carolina gynecologists' survey at
the conclusion of a 2-day meeting at the
RAND Corporation to discuss and rate
the appropriateness oftheir elective indica-
tions for hysterectomy.8'9
Survey Questionnaire
The questionnaire asked about per-
sonal and practice characteristics and the
appropriateness of performing hysterec-
tomy for 32 clinical scenarios. Sixteen
scenarios covered the most prevalent
indication for hysterectomy (fibroids);
eight concerned a common equivocal
indication (cervical dysplasia); four cov-
ered a common subjective indication in
North Carolina (cancer fear); and four
were on cancer.6 All scenarios concerned
women who did not desire future fertility
and who differed by age (35 vs 45 years
old) and by disease severity.
Appropriateness was considered in
tertiles, with median scores of 1 through 3
rated as inappropriate (risks outweigh
benefits), 3.5 through 6 as equivocal (risks
and benefits roughly equal), and 6.5
through 9 as appropriate (benefits out-
weigh risks).
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StatisticalAnalysis
We present median values because
the expert group was small and mean
values might be misleading. Overall agree-
ment between the experts and the commu-
nity gynecologists was assessed with the
Wilcoxon rank sum statistic. Agreement
within each group was assessed by an
intraclass correlation coefficient to deter-
mine whether each group agreed more
with its own members than could be
accounted for by chance alone and by a
second method that allowed, after discard-
ing one extremely high rating and one
extremely low rating, an examination of
whether the remaining seven ratings all
fell within the 3-point tertile containing
the median. This RAND method of
determining agreement was also used
with the community physicians by discard-
ing the top and bottom 10% of ratings and
then assessing whether the remaining
80% fell within one tertile of appropriate-
ness.
Results
The median number of hysterecto-
mies performed per month was three for
both experts and community gynecolo-
gists. Twenty-two percent of the experts
and 8% of the community gynecologists
had completed subspecialty training. A
much higher percentage of community
gynecologists' patients had private (fee for
service) insurance compared with the
managed care experts' patients (70% vs
10%; P < .0001). On average, experts
and community gynecologists graduated
from residency training in 1976.
Appropriateness
Overall, little difference existed be-
tween experts' and community gynecolo-
gists' appropriateness ratings. Both groups
rated hysterectomy as appropriate for all
4 cancer (cervical and endometrial) sce-
narios and for 13 of 16 fibroid scenarios
(Table 1). There was a statistically signifi-
cant difference between experts and com-
munity gynecologists regarding the appro-
priateness of hysterectomy for all cervical
dysplasia scenarios; for six of eight such
scenarios community gynecologists rated
hysterectomy more appropriate forwomen
with carcinoma in situ or significant dys-
plasia on punch or cone biopsy (Figure 1).
Agreement
The finding that few differences exist
between the experts and community gyne-
cologists, however, depends on the varia-
tion in appropriateness scores within each
group. Using the RAND tertile method
for assessing agreement, we found that
the experts agreed among themselves that
hysterectomy was appropriate for all
endometrial and cervical cancer scenarios
(4/4) and for 56% (9/16) of the fibroid
indications (Table 1). They agreed about
the inappropriateness of hysterectomy for
women with cancer fear but without
cancer risk factors for two of four sce-
narios and for women whose Pap smear
or cervical punch biopsy showed dysplasia
for four of eight scenarios. The experts
did not agree for nonanemic women with
bleeding fibroids, women with bleeding
fibroids and iron-responsive anemia,
women who feared cancer and had cancer
risk factors, women with dysplasia on
cone biopsy, and those with cervical
carcinoma in situ. Overall, experts agreed
among themselves on 19 of 32 indications
(59%), with the intraclass correlation
coefficient of 0.66 showing a relatively
good amount of agreement.
We found that North Carolina com-
munity gynecologists agreed among them-
selves about the appropriateness of hyster-
ectomy for endometrial cancer and for 10
of 16 fibroid scenarios (63%). They did
not agree with each other for either of the
two cervical cancer scenarios, the four
fear-of-cancer scenarios, eight cervical
dysplasia scenarios, and four bleeding-
fibroid scenarios in nonanemic and iron-
responsive anemic women. Overall, North
Carolina community gynecologists agreed
on only 12 of 32 clinical scenarios (38%),
with an intraclass correlation coefficient
of 0.50 showing only a moderate level of
agreement beyond chance alone.
Discussion
Even after 2 days of discussion about
the appropriateness of hysterectomy for
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TABLE 1-Hysterectomy Appropriateness: Median Scores and Agreement within
Physician Groups
NC Gynecologist
Expert Median (SD) Median (SD)
Clinical Scenario 35 y 45 y 35 y 45 y
Stage 1 endometrial cancer 9A (0) 9A (0) 9A (0.9) 9A (0.9)
Stage 1 cervical cancer 9A (0) 9A (0) 9NA (2.4) 9NA (2.4)
Dysplasia on Pap smear* 1 A (0.7) 1A (0.3) 1 NA (2.5) 1 NA (2.7)
Dysplasia on punch biopsy* 1 A (2.7) 1A (2.6) 5NA (2.8) 5NA (3.0)
Dysplasia on cone biopsy* 2.5NA (3.2) 3NA (3.2) 8NA (2.4) 8NA (2.2)
Cervical carcinoma in situ* 4NA (2.5) 4NA (2.5) 8NA (2.0) 8NA (1 9)
Cancer phobia without risk 1A (1.3) 1 A (1.7) 1 NA (1.8) 2NA (2.0)
factors**
Cancer phobia with risk factors 2NA (2.5) 2NA (2.5) 3.5NA (2.4) 4NA (2.5)
Bleeding fibroids with anemia 8A (1.2) 8A (1.1) 9A (1.2) 9A (1.2)
refractory to iron therapy*
Bleeding fibroids in a 5NA (0.9) 6NA (0.9) 6NA (1.1) 6NA (1.0)
nonanemic woman
Bleeding fibroids refractory 9A (2.1) 9A (2.4) 8A (2.1) 9A (2.0)
to conservative surgical
procedures
Bleeding fibroids with anemia 5NA (2.2) 6NA (2.3) 7NA (2.3) 7NA (2.3)
responding to iron
Painful fibroids in an otherwise 7NA (2.2) 6NA (2.1) 8NA (1.6) 7NA (1.7)
healthy woman
Painful fibroids refractory to 9A (1.6) 8A (1.3) 9A (1.1) 9A (1.2)
medical therapy and psycho-
logical counseling
Painfulfibroidsrefractorytocon- 9A (1.1) 8A (0.9) 9A (1.1) 9A (1.1)
servative surgical procedures
Painful fibroids refractory to oral 9NA (1.2) 7A (0.9) 9A (1.1) 9A (1.1)
medical therapy**
Note. Agreement was defined as all scores falling within tertiles of 1 through 3 (inappropriate), 3.5
through 6 (equivocal), or 6.5 through 9 (appropriate) after the top and bottom 10% of sample were
discarded for the North Carolina physicians and the high and low scores were discarded for the
HMO expert panel. A = Agreement; NA = no agreement.
*P < .05 by Wilcoxon rank sum test between experts and NC gynecologists for scenarios with 35-
and 45-yr-old women.
**P < .05 by Wilcoxon rank sum test between experts and NC gynecologists for scenarios with
45-year-old women.
various elective indications, experts did
not agree among themselves regarding
many common scenarios. They agreed,
however, more than community gynecolo-
gists, who rated the same scenarios with-
out a discussion of their differences of
opinion about the procedure. Although
community gynecologists rated hysterec-
tomy as more appropriate for cervical
dysplasia than did the experts, few other
differences existed between these groups
about the appropriateness of hysterec-
tomy. Previous reports found that mul-
tiple rounds of ratings and/or discussion
lead to greater agreement.9 Discussion
among groups of physicians and evalua-
tion of patient outcomes for clinical areas
with large practice variation and known
differences of opinion may be helpful in
reducing disagreement.
Those scenarios about which expert
panel members agreed on appropriate-
ness but community gynecologists did not
may represent areas in which expert-
derived guidelines could have the greatest
impact on community physician practice.
Although explicit criteria may help mini-
mize practice variation for agreed-on
scenarios, such criteria have less impact
on varying opinions for clinically uncer-
tain scenarios, a limitation of opinion-
derived guidelines. In our list of indica-
tions, these uncertain scenarios included
women with bleeding fibroids responsive
to treatment and women with moderate
to severe cervical dysplasia, two common
conditions in North Carolina for which up
to 45% of all hysterectomies are per-
formed.5
The small level of disagreement
between experts' and community physi-
cians' appropriateness ratings belies the
large variation in opinion that exists
within each group. This variation may
reflect uncertainty about a procedure
often done electively to improve quality of
life.10 Treatment choice and appropriate-
ness ratings are affected by clinical and
nonclinical factors including social charac-
teristics, patient preference, quality of
life, and process of medical care.1-15 For
areas of clinical uncertainty, these non-
clinical factors likely exert a greater
influence on decision making. Ideally,
empirical research should be used to
guide decision making. A recent out-
comes study of symptom relief and patient
satisfaction among women with bleeding
fibroids treated medically or surgically
provides an example of how information
can be used for treatment discussions
between patients with symptomatic fi-
broids and their gynecologists.16'17 How-
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Note. Median score indicated by the line drawn at 50% level of physician response on the vertical
axis. Statistical comparison with Wilcoxon test. NC = North Carolina gynecologists (n = 140);
Expert = expert panelists (n = 9); CIS = carcinoma in situ.
FIGURE 1-Expert and North Carolina community gynecologists' ratings of
hysterectomy as appropriate for women with cervical dysplasia.
ever, in the absence of such evidence,
opinion-derived guidelines provide some
framework for decision making. Although
this approach may not be optimal, it gives
a baseline reference point, a description
of current practice standards, and points
out areas for future research needed to
provide the evidence and rationale for
clinical areas of uncertainty.
Expert panelists were less likely to
rate hysterectomies as appropriate than
were North Carolina community gynecolo-
gists. This may have occurred because the
experts were all HMO clinicians, and a
goal of HMOs is to minimize inappropri-
ate procedures. In addition, practice
styles vary by region,'8 and the experts
were from all four major US census
regions. Because the South has the high-
est hysterectomy rate, regionality may
have contributed to the North Carolina
community gynecologists' higher ratings
of hysterectomy appropriateness.
Given our strict definition of agree-
ment, we would expect more disagree-
ment among a larger group because there
is a greater likelihood that a single
individual's ratings will fall outside the
median tertile. Although we did find more
disagreement in the larger group, in only 2
of the 32 scenarios was the disagreemeni
due to a few community gynecologists
ratings falling outside the median tertile.
Expert opinion-derived guidelines
are one method for providing a cohereni
approach to decisions about medical care
we have shown that problems with such
guidelines may arise in areas of marked
clinical uncertainty. Scenarios about which
neither experts nor community physicians
can agree should provide the focus for
future clinical studies.'9 Process of care,
quality of life, and patient preference
measures should be included in discus-
sions about appropriateness and guide-
line development,'3 particularly for clini-
cally uncertain conditions. O
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In the absence of large-scale random-
ized clinical trial data, the risks and
benefits of hormone replacement therapy
for postmenopausal women remain unre-
solved.1 2A recent meta-analysis of obser-
vational studies estimated that hormone
replacement therapy use carries reduced
relative risks of 0.65 for coronary heart
disease and 0.75 for fracture, but relative
risks of 0.96 for stroke and 1.25 for breast
cancer.2 Relative risk estimates for endo-
metrial cancer were 8.22 for estrogen
therapy and 1.00 for combination estro-
gen plus progestin therapy,2 although few
data on combination hormone replace-
ment therapy are available. Although the
clinical trial component of the Women's
Health Initiative3 should help resolve the
risk-benefit controversy, results will not
be available for over a decade and it
cannot address the long-term risks of
hormone replacement therapy. In the
meantime, additional observations on hor-
mone replacement therapy from contem-
porary cohort studies with multiple dis-
ease end points may be of use to health
professionals.
Methods
The Iowa Women's Health Study
cohort4'5 consists of 41 837 women aged
55 through 69 years who had a valid Iowa
driver's license in 1985.A mailed question-
naire provided information on current
and past hormone replacement therapy,
prevalent diseases, anthropometric data,
and other risk factors. Hormone replace-
ment therapy was determined by the
following questions: "Have you ever used
pills other than birth control pills which
contained estrogen or other female hor-
mones (e.g., at the change of life or
menopause, after surgery, or at another
time)?" and, if yes, "How long did you
take estrogens or other female hormone
pills (other than birth control pills)?"
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